Viant is not listed even in the top 20 (or top 40) medical device makers. Having Dr. Koneru working ‘quietly’ in this environment enables the ‘quiet’ development of an enhanced Actipatch/RecoveryRx PEMF device that can take place away from prying eyes. Doing this kind of research w/in a huge company, e.g. - GE Healthcare, runs the risk of either being stolen or undermined. Keep it quiet until you are ready. If Viant needs more manufacturing capacity that is easily arranged.
https://thecconnects.com/top-20-medical-devic...facturers/ (no Viant)
https://www.mddionline.com/business/top-40-me...-companies (no Viant)
According to the article posted by Chanel5, the current opioid addiction crisis is estimated to be costing the US taxpayers a cool $1.2 TRILLION. If non-invasive PEMF medical devices are capable of reducing that cost by only 10%, we are talking about a market size of $120 BILLION. That kind of money attracts many deep-pocketed investors. Check out the graphic below courtesy of Hawk05.
According to normal investor on the other board (Post #346,701 ), 65.51% of Float is held by Institutions. They, the institutions holding those shares, have had plenty of time to dump those shares. Yet, they have NOT dumped those shares. Again, on the other board, it has been reported that BIEL has changed their corporate description - poster 3331, Post #346,662 - to “an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.” There are no coincidences.
The_Pro 11/14/25 1:17 PM
Post #345670 on Bioelectronics Corp (BIEL)
This was in the works years ago when Sree Koneru "LEFT" for Viant. Takes a long time to gear up for everything.
"Sic parvis magna" - Greatness from small beginnings
All the best, WBeacham